In the field of biomedicine, hypoxia-inducible factor 1-alpha (HIF-1α) is undoubtedly a focus of attention. This protein plays a key role in coping with hypoxic conditions and has even been hailed as key to survival. HIF-1α is one of the subunits of the heterodimeric transcription factor HIF-1, which is mainly responsible for regulating cellular responses to insufficient oxygen supply.
HIF-1α is considered to be the master transcription factor controlling cellular and developmental responses to hypoxia.
The significance of HIF was reaffirmed in 2019 by the awarding of the Nobel Prize in Physiology or Medicine, which is awarded to the scientist who discovered HIF. The activity of HIF-1α is closely related to many biological processes, including angiogenesis, cell survival, and tumor invasion and metabolic regulation.
HIF-1 is a heterodimer composed of HIF-1α (α subunit) and aryl hydrocarbon receptor nuclear transporter (Arnt) (β subunit). The structure of HIF-1α includes a basic helix-loop-helix (bHLH) structure and two PAS (PER-ARNT-SIM) domains, allowing it to function in the nucleus.
HIF-1α regulates its gene expression through a GC-rich promoter and is continuously expressed at low levels under normal oxygen conditions.
HIF1A expression is driven by hypoxia, and HIF1A transcription is significantly upregulated when oxygen concentration decreases. Its expression is controlled by an oxygen-dependent degradation mechanism, which allows HIF-1α to exist stably in a hypoxic environment, thereby promoting the expression of a series of survival-related genes.
HIF-1 is important in the response to systemic oxygen levels in mammals. Its activity is regulated by post-translational modifications such as hydroxylation, acetylation and phosphorylation. HIF-1 can induce the transcription of more than 60 genes, which are involved in biological processes such as angiogenesis and erythropoiesis, and can improve the ability of oxygen to be delivered to hypoxic areas.
Under normal circumstances, HIF-1α is degraded, but under hypoxic conditions it accumulates and forms heterodimers with HIF-1β. ”
In the process of wound repair, the role of HIF-1α has also been deeply discussed by the scientific community. Studies have shown that continued upregulation of HIF-1α may promote the regeneration of damaged tissue, while its continued downregulation may lead to the formation of scar tissue.
Overexpression of HIF-1α is closely related to various human cancers, especially tumor growth and metastasis. Many experiments have shown that overexpression of HIF-1α is one of the main factors promoting tumor angiogenesis and cell metabolism regulation. In fact, in most solid tumors, the expression of HIF-1α increases significantly, which is related to tumor aggressiveness and prognosis.
Clinical studies have shown that mild HIF1A expression can predict the malignant progression of tumors and resistance to treatment.
Cancer treatment researchers have recognized the importance of HIF-1α as a therapeutic target, but current therapies targeting HIF-1α still present challenges. This makes more in-depth mechanistic studies a current focus in order to find new treatment strategies.
In summary, HIF-1α not only plays an important regulatory role in a hypoxic environment, but also plays an indispensable role in various biological processes. Its potential in cancer and regenerative medicine is even more obvious. As the scientific community's understanding of HIF-1α deepens, will there be revolutionary treatments targeting HIF-1α in the future to improve the prognosis of cancer patients? This once again arouses our thinking?